Skip to main content

Freia launches ImmunoV Forte, an EFSA compliant nutritional supplement that improves and protects respiratory function against airborne infections

Written by Customer Service on . Posted in Public Companies.

MONTRÉAL, April 08, 2020 (GLOBE NEWSWIRE) — Elixxer Ltd. (TSX-V: ELXR)  (OTC-QB: ELXIF) (FRA 2QLA) (“ELIXXER” or (the “Company”) is pleased to announce that its pharmaceutical partner, Freia launches production of ImmunoV Forte, to improve and protect respiratory function in the human body against airborne infections.   
Freia is initiating clinical trials on the active ingredients in ImmunoV Forte that aid and protect the human respiratory tract from external environmental attacks such as respiratory viruses, bacteria, smoke and pollution.  In being compliant with Canadian Exchange regualators, both Elixxer and Freia are not making any expressed or implied claims that its product has the ability to eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time.  Post trials the company will update the market as to these resultsThe product will be available for sale in Europe by mid-April ImmunoV. Forte is a nutritional supplement that is water soluble, and can be taken once daily to protect and enhance against infection. According to EFSA, by continual use of the combined ingredients within ImmunoV Forte, Freia’s research and development team concluded that by using this product, it can contribute to improving the normal functions of the immune system. ImmunoV Forte contributes to the maintenance of normal immune system function even during and after intense physical activities or stresses.  ImmunoV Forte also contributes to protect cells from Oxidative stress and the normal metabolism of fatty acids in the human body.Friea has also confirmed with Elixxer that its current production facilities and laboratories will remain open amid this crisis, Freia’s operations are deemed as an essential pharmaceutical business.Freia and Elixxer are committed to bring Freia’s catalogue of medical products to market to protect and enhance the overall health of consumers throughout Europe, the UK and North America. About Elixxer Ltd. (www.Elixxer.com)ELXR Ltd. is a Canadian public company listed on the TSX Venture Exchange (TSXV: ELXR),  the US OTC-QB exchange (OTCQB: ELXIF) and Frankfurt (FRA: 2QLA)Through its partners ELXR presently has significant interests in Australia, Jamaica, Switzerland, Italy and Canada.About Freia Farmaceutici Srl (http://www.freiafarmaceutici.it/)

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.